Published January 12, 2018
Cancer biomarkers are used to trace and indicate the biological state of a tumour and thus analyse diagnostic and prognostic stages of cancer. Cancer biomarkers are into various fields such as drug discovery, development, personalised medicine, and diagnostics. Diagnostics is the principal revenue-generating application of market relating to factors such as increasing growth of biomarker-based oncology tests with higher sensitivity.
The Middle East and Africa Cancer Biomarkers Market Segments Size & growth:
The market is valued at USD 0.952 Billion in 2017 and is expected to reach USD 1.806 Billion by 2024 at a CAGR of 11.69%. The major Key factors influencing the market growth are an increase in awareness among patients and healthcare professionals about the necessity of early diagnostics of malignance’s and rising demand for personalised medicine is anticipated to provide the market with significant growth.
The Middle East and Africa Cancer Biomarkers Market Segments Share:
Cancer type segments cancer biomarkers market into breast cancer, lung cancer, colorectal cancer, melanoma; prostate, thyroid etc. over all these breast cancers is holding the most significant share in the market due to the prevalence of breast cancer and awareness about the diagnosis. The cancer biomarkers market is segmented by type, disease, service, application, and technologies. By type, the market is categorised into protein biomarkers, genetic biomarkers, cell biomarkers, viral biomarkers, carbohydrate biomarkers. By disease, the market is classified into prostate cancer, lung cancer, breast cancer, colorectal cancer and cervical cancer. By service, the market is categorised into sample preparation, assay development, biomarkers validation and testing. By application, the market is classified into risk assessment, development of molecular diagnostics, disease diagnostics, drug discovery, and development. By technologies, the market is categorised into Omics technologies, imaging technologies, cytogenetics, bioinformatics and IVD multivariate index assays. Geographically, cancer biomarker market is analysed under various countries, Mexico, Argentina and Brazil. Mexico is dominating one in cancer biomarkers market and is estimated to grow at highest rate during the forecast.
The Middle East and Africa Cancer Biomarkers Market Trends:
The Middle East and Africa Cancer Biomarkers Market Research Report Includes:
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.4. SWOT Analysis
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1.1 Increase in corporate partnerships to accelerate development and commercialise of regenerative medicine.
4.1.2 Increase in global healthcare expenditure.
4.1.3 Rapid growth in ageing population.
4.1.4. Prevalence of chronic diseases and genetic disorders.
4.2.1 Cost of treatment.
4.2.2 Complex regeneration process.
4.2.3. Lack of guidelines.
4.2.4. Ethical concerns with the use of embryonic stem cell for research and development.
4.3.1. Strong product pipeline.
4.3.2. The great demand for organ transplantation.
4.4.1 Stringent regulatory policies about stem cell technologies.
5. The Middle East and Africa Cancer Biomarkers Market – By Disease
5.2 Prostate cancer
5.3 Lung cancer
5.4 Cervical cancer
5.5 Colorectal cancer
5.6 Breast cancer
6. The Middle East and Africa Cancer Biomarkers Market – By Application
6.2 Risk assessment
6.3 Disease diagnostics
6.4 Development of molecular diagnostics
6.5 Drug formation
7. The Middle East and Africa Cancer Biomarkers Market – By Service
7.2 Sample preparation
7.3 Assay development
7.4 Biomarkers validation and testing
8. The Middle East and Africa Cancer Biomarkers Market – By Type
8.2 Protein biomarkers
8.3 Cell biomarkers
8.4 Genetic biomarkers
8.5 Carbohydrate biomarkers
8.6 Viral biomarkers
9. Middle East and Africa Cancer Biomarkers Market – By Technology
9.2 Omics technology
9.4 Imaging technologies
9.5 Immuno Assays
9.7 IVD multivariate
9.8 Index assays
10. Middle East and Africa Cancer Biomarkers Market – By Country
10.1 The Middle East and Africa
10.1.2 Saudi Arabia
11. The Middle East and Africa Cancer Biomarkers Market – Company Profiles
11.1 Affymetrix Inc
11.2 Agendia BV
11.3 Abbott Laboratories
11.4 Roche Diagnostics Corp.
11.5 Agilent Technologies
11.6 Astex Pharmaceuticals
11.7 Illumina Inc
11.8 Diadexus Inc
11.9 Qiagen N.V
11.10 Aureon Biosciences Inc
11.11 Becton, Dickinson and Company
11.12 Beckman Coulter Inc
11.13 Clarient Inc
11.14 Astellas Pharma US Inc
12. The Middle East and Africa Cancer Biomarkers Market – Competitive Landscape
12.1 Market Share Analysis
12.2 Strategies Adopted by top companies
12.3 Merges, Acquisitions, Collaborations & Agreements
13. Market Insights
13.1 Industry Experts Insights
13.2 Analysts Opinions
13.3 Investment Opportunities
14.1 List of tables
14.2 List of figures